Get started
Author

S. Faria

Observed names: S-L. Faria, S.L. Faria
OpenAlex ID: A5111600745
The Challenge of Scoring Radiation-induced Lung Toxicity
2009 · S.L. Faria, M. Aslani, et al. · Clinical Oncology · 21
193 Does the RTOG/EORTC scoring schema (RESS) truly reflect the late radiation morbidity in lung cancer patients?
2005 · M. Aslani, S-L. Faria, et al. · Radiotherapy and Oncology · 21
A Phase II Study of Accelerated Hypofractionated 3-dimensional Conformal Radiation Therapy for Inoperable T1-3 N0 M0 Non-small Cell Lung Cancer: NCIC CTG BR.25
2012 · P. Cheung, S. Faria, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
226 Timing of androgen deprivation therapy after radical radiotherapy failure — A survey of Canadian practitioners
2006 · P.C. Cheung, D.A. Loblaw, et al. · Radiotherapy and Oncology · 2
69 Preliminary results with hypofractionated radiation therapy (HRT) alone as the curative treatment for patients with early stage, medically inoperable non-small cell lung cancer (NSCLC)
2005 · S. Faria, L. Souhami, et al. · Radiotherapy and Oncology · 2
PO-0755: Can dose proximal to the PTV influence the risk of distant metastases in SBRT lung cancer patients?
2018 · A. Diamant, A. Chatterjee, et al. · Radiotherapy and Oncology · 1
PDF
122 A phase-II Trial of intermittent androgen ablation in patients presenting biochemical failure after definitive radiotherapy for localized prostate cancer
2005 · F. Cury, L. Souhami, et al. · Radiotherapy and Oncology · 1
Comprehensive Assessment of Pneumonitis, Pseudoprogression and Hyperprogression among Inoperable Stage III NSCLC Patients Treated with Trimodal Therapy
2024 · J. Paragas, M. Duclos, et al. · International Journal of Radiation Oncology*Biology*Physics
Hypofractionated Intensity Modulated Radiation Therapy and Weekly Gemcitabine for Muscle Invasive Bladder Cancer. Long-Term Results
2024 · T.Y.T. De Souza, L. Souhami, et al. · International Journal of Radiation Oncology*Biology*Physics
Outcomes of Hypofractionated Radiotherapy with Induction or Sequential Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Single Institution Experience
2023 · I.J. Gerard, N. Rastogi, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Can Dose Metrics Predict Distant Metastases in SBRT Non–small Cell Lung Cancer Patients?
2017 · A.A. Diamant, I. El Naqa, et al. · International Journal of Radiation Oncology*Biology*Physics
Po-0663 Downsizing and Downstaging of Rectal Cancer After Short Course Radiotherapy Followed by Delayed Surgery
2012 · S. Faria, N. Kopek, et al. · Radiotherapy and Oncology
Can combined chemo-radiation be started after induction chemotherapy in the curative treatment of stage III non-small cell lung carcinoma (NSCLC)? A multicenter, phase II study 5-year update.
2011 · S. Faria, S. P. Owen, et al. · Journal of Clinical Oncology
1125 POSTER Chemotherapy has no impact on acute and late skin toxicity when combined with a hypofractionated regimen of breast irradiation
2007 · A.N. Al Hamad, T. Hijal, et al. · European Journal of Cancer Supplements
4040 POSTER Salvage 3-D conformal radiation therapy for patients developing biochemical failure post prostatectomy: a single institution experience
2007 · B. Joshua, M. Duclos, et al. · European Journal of Cancer Supplements
4021 POSTER Testosterone recovery following prolonged adjuvant androgen blockade in localized prostate cancer: is there an effect on outcome?
2007 · B.B. Joshua, L. Souhami, et al. · European Journal of Cancer Supplements
192 Ten years experience with small cell lung cancer (SCLC) — limited stage (LS) at the McGill University Health Centre
2005 · T-M. Niazi, S-L. Faria, et al. · Radiotherapy and Oncology
P-715 Hypofractionated radiation therapy (HRT) alone as the curative treatment for patients with early stage, medically inoperable non-small cell lung cancer (NSCLC)
2005 · S. Faria, L. Souhami, et al. · Lung Cancer
Works count: 18
Citation count: 51
H-index: 3
I10-index: 2
Year
Topic
Type